Image Credit: STAT News
STAT+: The biotech scorecard for the second quarter: 24 stock-moving events to watch
Here is STAT’s biotech scorecard for the second quarter. Plus, a rundown of FDA-sponsor meetings that could be a clue to changes under Trump.